Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 5, 2010, Pages 527-532

  Hiraki, Y ^a   Onga, T ^a   Mizoguchi, A ^b   Tsuji, Y ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b SASEBO CHUO HOSPITAL   (Japan)

Author keywords

patient specific parameters; pharmacokinetics; prediction accuracy; therapeutic drug monitoring; vancomycin

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BAYES THEOREM; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; JAPANESE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BAYES THEOREM; DRUG MONITORING; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; YOUNG ADULT;

EID: 77956642071     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01126.x     Document Type: Article

References (20)

1. Schentag JJ, Hyatt JM, Carr JR et al. (1998) Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clinical Infectious Diseases, 26, 1204 1214.
2. Farber BF, Moellering RC, Jr. (1983) Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy, 23, 138 141.
3. Forouzesh A, Moise PA, Sakoulas G (2009) Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrobial Agents and Chemotherapy, 53, 483 486.
4. Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH (1990) Nephrotoxicity of vancomycin, alone and with an aminoglycoside. Journal of Antimicrobial Chemotherapy, 25, 679 687.
5. Sheiner LB, Beal S, Rosenberg B, Marathe VV (1979) Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics, 26, 294 305.
6. Sheiner LB, Rosenberg B, Melmon KL (1972) Modelling of individual pharmacokinetics for computer-aided drug dosage. Computers and Biomedical Research, 5, 411 459.
7. Iwamoto T, Kagawa Y, Kojima M (2003) Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biological and Pharmaceutical Bulletin, 26, 876 879.
8. Llopis-Salvia P, Jimenez-Torres NV (2006) Population pharmacokinetic parameters of vancomycin in critically ill patients. Journal of Clinical Pharmacy and Therapeutics, 31, 447 454.
9. Teramachi H, Hatakeyama H, Matsushita R, Imai Y, Miyamoto K, Tsuji A (2002) Evaluation of predictability for vancomycin dosage regimens by the Bayesian method with Japanese population pharmacokinetic parameters. Biological and Pharmaceutical Bulletin, 25, 1333 1338.
10. Pea F, Bertolissi M, Di Silvestre A, Poz D, Giordano F, Furlanut M (2002) TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients. International Journal of Antimicrobial Agents, 20, 326 332.
11. Yasuhara M, Iga T, Zenda H et al. (1998) Population pharmacokinetics of vancomycin in Japanese adult patients. Therapeutic Drug Monitoring, 20, 139 148. (Pubitemid 28163195)
12. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31 41.
13. Yano YOT (1997) A pharmacokinetic analysis software for TDM based on the Bayesian estimation using Visual Basic. Japanese Journal of Therapeutic Drug Monitoring, 14, 179 188.
14. Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics, 9, 503 512.
15. Smythe M, Hoffman J, Kizy K, Dmuchowski C (1994) Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. American Journal of Hospital Pharmacy, 51, 198 204.
16. Nakamura T, Wakaki N, Kimura Y, Goto N, Masada M (1996 Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics Yakugaku Zasshi, 116, 876 883.
17. Polard E, Le Bouquin V, Le Corre P et al. (1999) Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients. Therapeutic Drug Monitoring, 21, 395 403.
18. Pou L, Rosell M, Lopez R, Pascual C (1996) Changes in vancomycin pharmacokinetics during treatment. Therapeutic Drug Monitoring, 18, 149 153.
19. Bertino JS, Jr. (1993) Measured versus estimated creatinine clearance in patients with low serum creatinine values. Annals of Pharmacotherapy, 27, 1439 1442.
20. Guay DR, Vance-Bryan K, Gilliland S, Rodvold K, Rotschafer J (1993) Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster. Journal of Clinical Pharmacology, 33, 918 922.